Literature DB >> 11435246

Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation.

K C Meyer1, D R Nunley, J H Dauber, A T Iacono, R J Keenan, R D Cornwell, R B Love.   

Abstract

Neutrophils are sequestered in the newly transplanted lung after reperfusion or with infection, rejection, and chronic graft dysfunction. Because unopposed (free) neutrophil elastase (NE) released into bronchoalveolar secretions may injure the lung allograft and impair bacterial clearance, we assessed total neutrophil numbers, myeloperoxidase activity as an index of neutrophil influx and degranulation, alpha1-antiprotease (alpha1-AP) concentrations, and unopposed NE activity in bronchoalveolar secretions from lung transplant recipients. Unopposed NE activity was present in bronchoalveolar lavage fluid (BALF) from recipients transplanted for emphysema associated with alpha1-AP deficiency as well as recipients without such deficiency (171 of 2,137 BALF; 8%). Ten of 17 (59%) recipients with alpha1-AP deficiency who were followed for at least 1 yr after transplant with multiple surveillance and diagnostic bronchoscopies had at least one BALF containing unopposed NE, usually associated with the presence of > or = 10(5) colony forming units/ml BALF of aerobic bacteria. In contrast, 19 of 58 (33%) with emphysema not associated with alpha1-AP deficiency, 8 of 32 (25%) recipients with cystic fibrosis (CF), 6 of 16 (38%) with idiopathic pulmonary fibrosis (IPF), and 11 of 36 (31%) with other indications for transplant had unopposed NE in BALF. alpha1-AP levels were significantly elevated in the early posttransplant time period and could be augmented considerably in alpha1-AP-deficient recipients with episodes of infection or rejection. Our findings indicate that unopposed NE activity can be found in both alpha1-AP-deficient and alpha1-AP-sufficient recipients after transplantation, usually in association with endobronchial bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435246     DOI: 10.1164/ajrccm.164.1.2006096

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Authors:  X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls
Journal:  Am J Transplant       Date:  2015-02-27       Impact factor: 8.086

2.  Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; Erin Lowery; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Am Coll Surg       Date:  2013-04-28       Impact factor: 6.113

3.  Greater survival despite increased complication rates following lung transplant for alpha-1-antitrypsin deficiency compared to chronic obstructive pulmonary disease.

Authors:  John R Spratt; Roland Z Brown; Kyle Rudser; Umesh Goswami; Marshall I Hertz; Jagadish Patil; Irena Cich; Sara J Shumway; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

4.  Role of alloimmunity and autoimmunity in allograft rejection.

Authors:  Babak Banan; Zhongping Xu; Muthukumar Gunasekaran; T Mohanakumar
Journal:  Clin Transpl       Date:  2013

Review 5.  Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.

Authors:  V E Kennedy; J L Todd; S M Palmer
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

6.  Immune responses to self-antigens (autoimmunity) in allograft rejection.

Authors:  Sabarinathan Ramachandran; Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Clin Transpl       Date:  2012

7.  Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis.

Authors:  Francis H C Tsao; Zhuzai Xiang; Adnan Abbasi; Keith C Meyer
Journal:  BMC Pulm Med       Date:  2012-08-17       Impact factor: 3.317

8.  Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome.

Authors:  Matthew D Stone; Stephen B Harvey; Gary L Nelsestuen; Cavan Reilly; Marshall I Hertz; Chris H Wendt
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

9.  Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation.

Authors:  Salome R T Rehm; Natalia F Smirnova; Carmela Morrone; Jessica Götzfried; Annette Feuchtinger; John Pedersen; Brice Korkmaz; Ali Önder Yildirim; Dieter E Jenne
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

10.  Preservation with α1-antitrypsin improves primary graft function of murine lung transplants.

Authors:  Jessica Götzfried; Natalia F Smirnova; Carmela Morrone; Brice Korkmaz; Ali Önder Yildirim; Oliver Eickelberg; Dieter E Jenne
Journal:  J Heart Lung Transplant       Date:  2018-03-30       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.